Concerns about the safety of anti-TNF agents when treating rheumatic diseases.
Expert Opin Drug Saf. 2020 Jun;19(6):695-705. doi: 10.1080/14740338.2020.1763299. Epub 2020 May 13.
Expert Opin Drug Saf. 2020.
PMID: 32401624
Review.